Immunization of Rabbits with Highly Purified, Soluble, Trimeric Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Induces a Vigorous B Cell Response and Broadly Cross-Reactive Neutralization-Reference-Cited by-同舟云学术

Immunization of Rabbits with Highly Purified, Soluble, Trimeric Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Induces a Vigorous B Cell Response and Broadly Cross-Reactive Neutralization

Published:2014-05-20 Issue:5 Volume:9 Page:e98060
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Quinnan Gerald V.,Onabajo Olusegun,Zhang Pengfei,Yan Lianying,Mattapallil Joseph J.,Zhang Zhiqiang,Dong Ming,Lu Min,Montefiori David,LaBranche Celia,Broder Christopher C.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference37 articles.

1. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand;S Rerks-Ngarm;N Engl J Med,2009

2. HIV vaccines: lessons learned and the way forward;JH Kim;Curr Opin HIV AIDS,2010

3. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial;SP Buchbinder;Lancet,2008

4. A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals;LM Walker;PLoS Pathog,2010

5. Broad neutralization coverage of HIV by multiple highly potent antibodies;LM Walker;Nature,2011

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GALT CD4+PD-1hi T follicular helper (Tfh) cells repopulate after anti-retroviral therapy;Cellular Immunology;2021-08

2. Microbial Dysbiosis During Simian Immunodeficiency Virus Infection is Partially Reverted with Combination Anti-retroviral Therapy;Scientific Reports;2020-04-14

3. A Prime-Boost Immunization Strategy with Vaccinia Virus Expressing Novel gp120 Envelope Glycoprotein from a CRF02_AG Isolate Elicits Cross-Clade Tier 2 HIV-1 Neutralizing Antibodies;Vaccines;2020-04-07

4. Exploiting Natural Cross-reactivity between Human Immunodeficiency Virus (HIV)-1 p17 Protein and Anti-gp41 2F5 Antibody to Induce HIV-1 Neutralizing Responses In Vivo;Frontiers in Immunology;2017-06-30

5. Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine Research;Journal of Virology;2015-08